Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2021 Filed Apr 8, 2021 16:31 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008569 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 501 shares on July 13, 2021; 564 shares on July 30, 2021; 33 shares on April 6, 2022; 565 shares on July 30, 2022; 34 shares on April 6, 2023; and 565 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 501 shares on July 13, 2021; 564 shares on July 30, 2021; 33 shares on April 6, 2022; 565 shares on July 30, 2022; 34 shares on April 6, 2023; and 565 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:31 UTC |
Jensen GlennVP, Operations
|
Tax withholdingCommon Stock | 13 | $3.35 | $43.55 |
DisclosureSEC source: 0001437749-21-008569 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,916 F2 · kind: No stock was sold. In connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:31 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008569 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,802 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC |
Cysewski Gerald RDirector · CEO
|
Tax withholdingCommon Stock | 13 | $3.35 | $43.55 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,087 F2 · kind: No stock was sold. On April 6, 2021, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC |
Cysewski Gerald RDirector · CEO
|
Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 15:04 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCyanotech common stock options · Derivative | 8,000 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001437749-21-006448 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Mr. Jensen acquired 8,000 stock options on 7/1/2011, of which 800 options became exercisable on 7/1/2011, 1,600 options became exercisable on 7/1/2012, 2,400 options became exercisable on 7/1/2013 and 3,200 options became exercisable on 7/1/2014. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 15:04 UTC |
Jensen GlennVP, Operations
|
SaleCommon Stock | 7,486 | $3.87 | $28,970.82 |
DisclosureSEC source: 0001437749-21-006448 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,896 Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 15:04 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 8,000 | $3.58 | $28,640.00 |
DisclosureSEC source: 0001437749-21-006448 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:37 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCyanotech common stock options · Derivative | 8,000 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001437749-21-006230 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Ms Johansen acquired 8,000 stock options on 7/1/2011, of which 800 options became exercisable on 7/1/2011, 1,600 options became exercisable on 7/1/2012, 2,400 options became exercisable on 7/1/2013 and 3,200 options became exercisable on 7/1/2014. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:37 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
SaleCommon Stock | 8,000 | $3.96 | $31,680.00 |
DisclosureSEC source: 0001437749-21-006230 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,858 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 19:37 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 8,000 | $3.58 | $28,640.00 |
DisclosureSEC source: 0001437749-21-006230 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 20:15 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 21,845 | $2.58 | $56,360.10 |
DisclosureSEC source: 0001437749-20-024485 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 40,789 Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 20:15 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 20,000 | $2.58 | $51,600.00 |
DisclosureSEC source: 0001437749-20-024485 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 40,000 Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 20:09 UTC |
Menzel Walter BennettDirector
|
SaleCyanotech Corporation Common Stock | 41,845 | $2.58 | $107,960.10 |
DisclosureSEC source: 0001437749-20-024483 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,611 Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 13:45 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 28 | $3.00 | $84.00 |
DisclosureSEC source: 0001437749-20-019613 · rdgdoc.xml · nonDerivative · entry 4 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 18,944 F4 · price: These shares were bought in multiple transactions at a price of $3.00. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 13:45 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 620 | $3.00 | $1,860.00 |
DisclosureSEC source: 0001437749-20-019613 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 20,000 F2 · price: These shares were bought in multiple transactions at a price of $3.00. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 13:45 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 622 | $2.85 | $1,771.95 |
DisclosureSEC source: 0001437749-20-019613 · rdgdoc.xml · nonDerivative · entry 3 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 18,916 F3 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.79 to $2.85, inclusive. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 13:45 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 1,196 | $2.84 | $3,401.54 |
DisclosureSEC source: 0001437749-20-019613 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 19,380 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.78 to $2.85, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2, 3 and 4. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 14:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 3,973 | $2.83 | $11,237.23 |
DisclosureSEC source: 0001437749-20-019490 · rdgdoc.xml · nonDerivative · entry 4 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 18,294 F4 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.64 to $2.85, inclusive. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 14:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 268 | $2.81 | $752.60 |
DisclosureSEC source: 0001437749-20-019490 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 18,184 F2 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 14:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 923 | $2.58 | $2,381.80 |
DisclosureSEC source: 0001437749-20-019490 · rdgdoc.xml · nonDerivative · entry 3 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 14,321 F3 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.58 to $2.60, inclusive. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 14:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 1,000 | $2.59 | $2,588.00 |
DisclosureSEC source: 0001437749-20-019490 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 17,916 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.58 to $2.60, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2, 3 and 4. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 14:39 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 6,691 | $2.73 | $18,265.09 |
DisclosureSEC source: 0001437749-20-019343 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 13,398 F2 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 14:39 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 10,000 | $2.74 | $27,422.00 |
DisclosureSEC source: 0001437749-20-019343 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 16,916 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 15:37 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 1,707 | $2.46 | $4,192.56 |
DisclosureSEC source: 0001437749-20-019216 · rdgdoc.xml · nonDerivative · entry 4 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 6,707 F4 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.30 to $2.50, inclusive. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 15:37 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 1,916 | $2.44 | $4,672.55 |
DisclosureSEC source: 0001437749-20-019216 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 6,916 F2 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.30 to $2.50, inclusive. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 15:37 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 5,000 | $2.42 | $12,115.50 |
DisclosureSEC source: 0001437749-20-019216 · rdgdoc.xml · nonDerivative · entry 3 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nyracai Johnstone Davis GST Exempt Trust Disclosed balance after: 5,000 F3 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.30 to $2.48, inclusive. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 15:37 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 5,000 | $2.43 | $12,154.00 |
DisclosureSEC source: 0001437749-20-019216 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust Disclosed balance after: 5,000 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.30 to $2.48, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnotes 2, 3 and 4. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 15:48 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019018 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,716 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 15:43 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019016 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,167 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 15:41 UTC |
KATZ NANCY EDirector
|
GrantCyanotech Corporation Common Stock | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019014 · rdgdoc.xml · nonDerivative · entry 1 KATZ NANCY E · CIK 0001189692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,167 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 15:38 UTC |
Menzel Walter BennettDirector
|
GrantCyanotech Corporation Common Stock | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019012 · rdgdoc.xml · nonDerivative · entry 1 Menzel Walter Bennett · CIK 0001586458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,456 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 15:35 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 12,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019010 · rdgdoc.xml · nonDerivative · entry 4 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 477,048 Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:32 UTC |
Nordin Amy BethVP, HR, Secretary
|
GrantRestricted Stock Units · Derivative | 1,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016343 · rdgdoc.xml · derivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610 Underlying: Common Stock · 1,207 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 303 shares on July 13, 2021; 402 shares on July 30, 2021; 33 shares on April 6, 2022; 402 shares on July 30, 2022; 34 shares on April 6, 2023; and 403 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 303 shares on July 13, 2021; 402 shares on July 30, 2021; 33 shares on April 6, 2022; 402 shares on July 30, 2022; 34 shares on April 6, 2023; and 403 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:28 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
GrantRestricted Stock Units · Derivative | 1,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016340 · rdgdoc.xml · derivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,942 Underlying: Common Stock · 1,588 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 254 shares on July 13, 2021; 530 shares on July 30, 2021; 33 shares on April 6, 2022; 529 shares on July 30, 2022; 34 shares on April 6, 2023; and 529 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 254 shares on July 13, 2021; 530 shares on July 30, 2021; 33 shares on April 6, 2022; 529 shares on July 30, 2022; 34 shares on April 6, 2023; and 529 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:23 UTC |
ORLOPP BRIAN BRETTCFO, VP Fin & Admin
|
GrantRestricted Stock Units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016338 · rdgdoc.xml · derivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP Fin & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:20 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
GrantRestricted Stock Units · Derivative | 1,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016336 · rdgdoc.xml · derivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,029 Underlying: Common Stock · 1,494 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 435 shares on July 13, 2021; 498 shares on July 30, 2021; 33 shares on April 6, 2022; 498 shares on July 30, 2022; 34 shares on April 6, 2023; and 498 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 435 shares on July 13, 2021; 498 shares on July 30, 2021; 33 shares on April 6, 2022; 498 shares on July 30, 2022; 34 shares on April 6, 2023; and 498 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:15 UTC |
Jensen GlennVP, Operations
|
GrantRestricted Stock Units · Derivative | 1,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016333 · rdgdoc.xml · derivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,295 Underlying: Common Stock · 1,694 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The retricted stock units vest as to 33 shares on April 6, 2021; 501 shares on July 13, 2021; 564 shares on July 30, 2021; 33 shares on April 6, 2022; 565 shares on July 30, 2022; 34 shares on April 6, 2023; and 565 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The retricted stock units vest as to 33 shares on April 6, 2021; 501 shares on July 13, 2021; 564 shares on July 30, 2021; 33 shares on April 6, 2022; 565 shares on July 30, 2022; 34 shares on April 6, 2023; and 565 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:07 UTC |
Cysewski Gerald RDirector · CEO
|
GrantRestricted Stock Units · Derivative | 1,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016330 · rdgdoc.xml · derivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Underlying: Common Stock · 1,999 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:11 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 303 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015224 · rdgdoc.xml · derivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403 Underlying: Common Stock · 303 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F3 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 303 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F3 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 303 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:11 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 303 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015224 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:08 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
Exercise / conversionRestricted Stock Units · Derivative | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015222 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 Underlying: Common Stock · 254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 254 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 254 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:08 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
Tax withholdingCommon Stock | 96 | $2.25 | $216.00 |
DisclosureSEC source: 0001437749-20-015222 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518 F2 · kind: No stock was sold. In connection with the vesting of 254 shares of stock, the Company withheld a total of 96 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:08 UTC |
Custer Matthew KeithVice President, Gen Mgr
|
Exercise / conversionCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015222 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Vice President, Gen Mgr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:05 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionRestricted Stock Units · Derivative | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015220 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 Underlying: Common Stock · 435 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 435 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 435 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:05 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Tax withholdingCommon Stock | 164 | $2.25 | $369.00 |
DisclosureSEC source: 0001437749-20-015220 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,858 F2 · kind: No stock was sold. In connection with the vesting of 435 shares of stock, the Company withheld a total of 164 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:05 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015220 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:01 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015218 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601 Underlying: Common Stock · 502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 501 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 501 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 19:01 UTC |
Jensen GlennVP, Operations
|
Tax withholdingCommon Stock | 189 | $2.25 | $425.25 |
DisclosureSEC source: 0001437749-20-015218 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,382 F2 · kind: No stock was sold. In connection with the vesting of 502 shares of stock, the Company withheld a total of 189 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.